Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The DEPT. OF THE ARMY -- USAMRAA has issued a Tender notice for the procurement of a Dow Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award in the USA. This Tender notice was published on 05 May 2026 and is scheduled to close on 30 Sep 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140656175, while the tender notice number is HT942526ALSRPTDA and Registering on the platform.
Procurement Summary
Country: USA
Summary: Dow Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Deadline: 30 Sep 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656175
Document Ref. No.: HT942526ALSRPTDA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
73110000 - Research servicesPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Summary: The Fiscal Year 2026 (Fy26) Amyotrophic Lateral Sclerosis Research Program (Alsrp) Therapeutic Development Award (Tda) Supports Research Ranging From Preclinical Validation Of Therapeutic Leads Through U.S. Food And Drug Administration (Fda) Investigational New Drug (Ind)-Enabling Studies. The Proposed Studies Are Expected To Be Empirical In Nature And Product-Driven. Applicants With Limited Amyotrophic Lateral Sclerosis (Als) Experience Are Strongly Encouraged To Include Collaborators With Substantial Experience In The Relevant Als Model Systems, Endpoints And Pathophysiology.Applications Supported By This Award Must Begin With Lead Compounds In Hand And Must Already Demonstrate Proof-Of-Concept Efficacy Data In At Least One Appropriate Preclinical Model System Of Als, Including Whole-Animal And Cellular Model Systems.Distinctive Features: Mechanism-Specific, Predictive/Cohort-Selective, Target Engagement And Pharmacodynamic Biomarker Development, In Parallel To The Main Therapeutic Effort, Is A Critical Component Of The Fy26 Alsrp Therapeutic Development Award. If Appropriate Mechanism-Specific Biomarkers Are Already Available Or Currently In Development, How The Existing Biomarkers Will Improve Trial Design, Patient Selection, And Efficiency Or Interpretation Of The Proposed Als Therapeutic Approach Must Be Apparent In The Application. Development Of Biomarkers For The Purposes Of Diagnosis, Prognosis, Or Measurement Of General Disease Progression Without Consider...
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Similar Tenders
USA
149969692
27 Oct 2026
Refer Document
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google